Disease Monitoring In Multiple Myeloma

被引：1
|
作者：
Hillengass, Jens [1 ]
Martin, Tom [2 ]
Puig, Noemi [3 ]
Paiva, Bruno [4 ]
Usmani, Saad [5 ]
Kumar, Shaji [6 ]
San-Miguel, Jesus [4 ,7 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[2] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[3] Dept Hematol Salamanca, Salamanca, Spain
[4] Clin Univ Navarra, CCUN, CIMA, CIBERONC,IDISNA, Pamplona, Spain
[5] Levine Canc Inst Atrium Hlth, Charlotte, NC USA
[6] Mayo Clin, Dept Hematol, Rochester, MN USA
[7] Clin Univ Navarra, Pio 12 Ave 36, Pamplona 31008, Spain
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷 / 04期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; IMAGING TECHNIQUES; COMPLETE RESPONSE; SURVIVAL; DIAGNOSIS; THERAPY; CORRELATE; PATTERNS;
D O I：
10.1016/j.clml.2023.01.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：244 / 248
页数：5
相关论文
共 50 条
  • [1] Minimal residual disease monitoring in multiple myeloma
    Davies, FE
    Rawstron, RC
    Owen, RG
    Morgan, GJ
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 197 - 222
  • [2] Sensitive multiple myeloma disease monitoring by mass spectrometry
    Rasa Santockyte
    Chelsea Jin
    James Pratt
    Ron Ammar
    Keyur Desai
    Mohan Bolisetty
    Prianka Das
    Mihaela Popa-McKiver
    Oscar Puig
    Blood Cancer Journal, 11
  • [3] Sensitive multiple myeloma disease monitoring by mass spectrometry
    Santockyte, Rasa
    Jin, Chelsea
    Pratt, James
    Ammar, Ron
    Desai, Keyur
    Bolisetty, Mohan
    Das, Prianka
    Popa-McKiver, Mihaela
    Puig, Oscar
    BLOOD CANCER JOURNAL, 2021, 11 (04)
  • [4] Advances in minimal residual disease monitoring in multiple myeloma
    Wijnands, Charissa
    Noori, Somayya
    van de Donk, Niels W. C. J.
    VanDuijn, Martijn M.
    Jacobs, Joannes F. M.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (07) : 518 - 534
  • [5] Predicting Outcomes and Monitoring Disease in Patients With Multiple Myeloma
    Kim, Susanna
    Berenson, James R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (09) : 484 - 493
  • [6] BONE BIOMARKERS ARE USEFUL IN MONITORING MYELOMA BONE DISEASE AND AS EARLY PREDICTOR FOR RELAPSE DISEASE IN MULTIPLE MYELOMA
    Ting, K.
    Hameed, A.
    Brady, J.
    Carke, C.
    Justine, M.
    Dowling, P.
    Clynes, M.
    O'Gorman, P.
    HAEMATOLOGICA, 2013, 98 : 334 - 335
  • [7] MONITORING OF THE MINIMUM RESIDUAL DISEASE AND DEPTH OF RESPONSE IN MULTIPLE MYELOMA
    Martinez-Lopez, J.
    Wong, S.
    Shah, N.
    Bahri, N.
    Zhou, K.
    Martin, T.
    Wolf, J.
    HAEMATOLOGICA, 2019, 104 : 150 - 150
  • [8] MULTIPLE MYELOMA: MONITORING OF REMISSION
    Orfao, Alberto
    Prez-Andres, Martin
    Almeida, Julia
    Mateo, Gema
    Lopez, Antonio
    Rasillo, Ana
    Vidriales, Belen
    Lopez Berges, Maria Consuelo
    San Miguel, Jesus
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 410 - 410
  • [9] Tumour markers for monitoring minimal residual disease in multiple myeloma.
    Rothwell, DG
    Kalakonda, N
    Norton, JD
    Hawkins, RE
    Chopra, R
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [10] Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
    Rocci, Alberto
    Gambella, Manuela
    Omede, Paola
    Drandi, Daniela
    Gay, Francesca
    Patriarca, Francesca
    Cavallo, Federica
    Petrucci, Maria Teresa
    Tommaso, Caravita
    Benevolo, Giulia
    Pescosta, Norbert
    Oliva, Stefania
    Offidani, Massimo
    Montefusco, Vittorio
    Liberati, Anna Marina
    Falcone, Antonietta Pia
    Ballanati, Stelvio
    Spadano, Tonino
    Guglielmelli, Tommasina
    Musto, Pellegrino
    Zarnbello, Renato
    Di Raimondo, Francesco
    Ladetto, Marco
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
12345